Neurizon Therapeutics LimitedASX: NUZ

Approval Received for a Clinical Study in Man with PPL-1

Feb 10, 2016 at 8:19 PM EST · Issued by Neurizon Therapeutics Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Neurizon Therapeutics into a list and get an email when it puts out news.